TGTX shares valued at $50.54 with P/E of 17.59
TG Therapeutics, Inc.’s share was trading at $50.54 as of June 16th.
The company’s trailing and forward P/E were 17.59 and 38.76 respectively.
TG Therapeutics is a commercial-stage biopharmaceutical company focused on treating multiple sclerosis.